Taiwan · Delayed Price · Currency is TWD Prince Pharmaceutical Statistics
Total Valuation
TPEX:6935 has a market cap or net worth of TWD 949.90 million. The enterprise value is 1.31 billion.
| Market Cap | 949.90M |
| Enterprise Value | 1.31B |
Important Dates
The next estimated earnings date is Friday, August 8, 2025.
| Earnings Date | Aug 8, 2025 |
| Ex-Dividend Date | Jun 21, 2024 |
Share Statistics
TPEX:6935 has 36.61 million shares outstanding. The number of shares has increased by 0.09% in one year.
| Current Share Class | 36.61M |
| Shares Outstanding | 36.61M |
| Shares Change (YoY) | +0.09% |
| Shares Change (QoQ) | +0.14% |
| Owned by Insiders (%) | 7.52% |
| Owned by Institutions (%) | 14.62% |
| Float | 12.81M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.38 |
| PB Ratio | 1.32 |
| P/TBV Ratio | 1.32 |
| P/FCF Ratio | 33.67 |
| P/OCF Ratio | 20.56 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 99.52, with an EV/FCF ratio of 46.36.
| EV / Earnings | -24.43 |
| EV / Sales | 1.90 |
| EV / EBITDA | 99.52 |
| EV / EBIT | n/a |
| EV / FCF | 46.36 |
Financial Position
The company has a current ratio of 1.56, with a Debt / Equity ratio of 0.64.
| Current Ratio | 1.56 |
| Quick Ratio | 0.93 |
| Debt / Equity | 0.64 |
| Debt / EBITDA | 35.06 |
| Debt / FCF | 16.33 |
| Interest Coverage | -4.81 |
Financial Efficiency
Return on equity (ROE) is -7.16% and return on invested capital (ROIC) is -2.52%.
| Return on Equity (ROE) | -7.16% |
| Return on Assets (ROA) | -2.24% |
| Return on Invested Capital (ROIC) | -2.52% |
| Return on Capital Employed (ROCE) | -4.43% |
| Revenue Per Employee | 3.29M |
| Profits Per Employee | -254,962 |
| Employee Count | 210 |
| Asset Turnover | 0.50 |
| Inventory Turnover | 4.33 |
Taxes
In the past 12 months, TPEX:6935 has paid 1.46 million in taxes.
| Income Tax | 1.46M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -3.39% in the last 52 weeks. The beta is 0.77, so TPEX:6935's price volatility has been lower than the market average.
| Beta (5Y) | 0.77 |
| 52-Week Price Change | -3.39% |
| 50-Day Moving Average | 23.08 |
| 200-Day Moving Average | 22.76 |
| Relative Strength Index (RSI) | 63.71 |
| Average Volume (20 Days) | 27,016 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:6935 had revenue of TWD 690.03 million and -53.54 million in losses. Loss per share was -1.46.
| Revenue | 690.03M |
| Gross Profit | 74.28M |
| Operating Income | -49.35M |
| Pretax Income | -52.08M |
| Net Income | -53.54M |
| EBITDA | 4.54M |
| EBIT | -49.35M |
| Loss Per Share | -1.46 |
Balance Sheet
The company has 102.80 million in cash and 460.80 million in debt, giving a net cash position of -357.99 million or -9.78 per share.
| Cash & Cash Equivalents | 102.80M |
| Total Debt | 460.80M |
| Net Cash | -357.99M |
| Net Cash Per Share | -9.78 |
| Equity (Book Value) | 722.06M |
| Book Value Per Share | 19.73 |
| Working Capital | 130.42M |
Cash Flow
In the last 12 months, operating cash flow was 46.21 million and capital expenditures -18.00 million, giving a free cash flow of 28.21 million.
| Operating Cash Flow | 46.21M |
| Capital Expenditures | -18.00M |
| Free Cash Flow | 28.21M |
| FCF Per Share | 0.77 |
Margins
Gross margin is 10.76%, with operating and profit margins of -7.15% and -7.76%.
| Gross Margin | 10.76% |
| Operating Margin | -7.15% |
| Pretax Margin | -7.55% |
| Profit Margin | -7.76% |
| EBITDA Margin | 0.66% |
| EBIT Margin | -7.15% |
| FCF Margin | 4.09% |
Dividends & Yields
This stock pays an annual dividend of 0.25, which amounts to a dividend yield of 0.96%.
| Dividend Per Share | 0.25 |
| Dividend Yield | 0.96% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 2 |
| Payout Ratio | n/a |
| Buyback Yield | -0.09% |
| Shareholder Yield | 0.86% |
| Earnings Yield | -5.64% |
| FCF Yield | 2.97% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TPEX:6935 has an Altman Z-Score of 1.46 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.46 |
| Piotroski F-Score | 3 |